HTG Molecular Diagnostics, Inc. (HTGM)
(Delayed Data from NSDQ)
$2.59 USD
+0.10 (4.02%)
Updated May 3, 2019 04:00 PM ET
After-Market: $2.58 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
HTG Molecular Diagnostics, Inc. [HTGM]
Reports for Purchase
Showing records 21 - 40 ( 90 total )
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
Bottom-Line Beat; 1Q21 Financials; Lowering PT to $9 Based on Dilution
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
Preliminary 1Q21 Financial Results; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
2020 Financial Results Reported; Reiterate Buy; Lowering PT to $11
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
Transcriptome Panel White Paper Indicates Broad Applicability; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
Preliminary 4Q20 Revenue Shows Recovery in Core Business; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
Reverse Stock Split Completed; Reiterate Buy with $15 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
White Paper on Whole Transcriptome Panel Released; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
New Oncology Profiling Assays and Software Launched; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
New Immuno-Oncology Profiling Applications Launching Soon; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
Profiling Menu Expanded With New NGS Platform Capability; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
HTG Launches EdgeSeq Pan B-Cell Lymphoma Panel; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
HTG EdgeSeq Platform Featured in Pharma AACR Posters; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
New Pan B-Cell Lymphoma Panel Unveiled; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
HTG Strengthens Position in Europe With Three New Distributors; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
1Q20 Financial Results Reported; Reiterate Buy; Lowering PT to $1
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
2019 Financial Results Reported; Reiterate Buy; Modulating PT to $1.50
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
2019 Preliminary Financial Results Reported; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
3Q19 Results Reported; Reiterate Buy; Lowering PT to $2 Due to Dilution
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y